BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

79 related articles for article (PubMed ID: 2577149)

  • 1. A search for common immunological abnormalities at the onset of murine lupus in two genetically different strains.
    Morrison LJ; Menzies CB; Behan WM; Behan PO
    J Clin Lab Immunol; 1989 Dec; 30(4):157-62. PubMed ID: 2577149
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunological abnormalities in BXSB mice at the onset of SLE development.
    Morrison LJ; Menzies CB; Behan WM; Behan PO
    J Clin Lab Immunol; 1990 May; 32(1):5-11. PubMed ID: 1967037
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Studies on the mechanisms of the development of lupus nephritis in BXSB mice. II. Comparative studies between male BXSB and MRL/lpr mice at the onset period.
    Makino M; Fujiwara M; Watanabe H
    J Clin Lab Immunol; 1988 Feb; 25(2):83-8. PubMed ID: 3259631
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dissociation of severe lupus-like disease from polyclonal B cell activation and IL 2 deficiency in C3H-lpr/lpr mice.
    Davidson WF; Roths JB; Holmes KL; Rudikoff E; Morse HC
    J Immunol; 1984 Aug; 133(2):1048-56. PubMed ID: 6610701
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Polyclonal B cell activation arises from different mechanisms in lupus-prone (NZB x NZW)F1 and MRL/MpJ-lpr/lpr mice.
    Merino R; Iwamoto M; Fossati L; Izui S
    J Immunol; 1993 Dec; 151(11):6509-16. PubMed ID: 7902378
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Responses of B cells from autoimmune mice to IL-5.
    Umland SP; Go NF; Cupp JE; Howard M
    J Immunol; 1989 Mar; 142(5):1528-35. PubMed ID: 2783944
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Regulation of plasma complement C4 and factor b levels in murine systemic lupus erythematosus.
    Garlepp MJ; Hart DA; Fritzler MJ
    J Clin Lab Immunol; 1989 Mar; 28(3):137-41. PubMed ID: 2738911
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Polyclonal B cell activation by a B cell differentiation factor, B151-TRF2. III. B151-TRF2 as a B cell differentiation factor closely associated with autoimmune disease.
    Dobashi K; Ono S; Murakami S; Takahama Y; Katoh Y; Hamaoka T
    J Immunol; 1987 Feb; 138(3):780-7. PubMed ID: 3543118
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Oncogene expression in autoimmune mice.
    Mountz JD; Mushinski JF; Mark GE; Steinberg AD
    J Mol Cell Immunol; 1985; 2(3):121-31. PubMed ID: 3916923
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long term administration of cyclophosphamide in MRL/1 mice. I. The effects on the development of immunological abnormalities and lupus nephritis.
    Shiraki M; Fujiwara M; Tomura S
    Clin Exp Immunol; 1984 Feb; 55(2):333-9. PubMed ID: 6607792
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Studies of T cell deletion and T cell anergy following in vivo administration of SEB to normal and lupus-prone mice.
    Scott DE; Kisch WJ; Steinberg AD
    J Immunol; 1993 Jan; 150(2):664-72. PubMed ID: 8419493
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Spontaneous B cell hyperactivity in autoimmune-prone MRL mice.
    Nijnik A; Ferry H; Lewis G; Rapsomaniki E; Leung JC; Daser A; Lambe T; Goodnow CC; Cornall RJ
    Int Immunol; 2006 Jul; 18(7):1127-37. PubMed ID: 16735376
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Administration of monoclonal anti-T cell antibodies retards murine lupus in BXSB mice.
    Wofsy D
    J Immunol; 1986 Jun; 136(12):4554-60. PubMed ID: 3086436
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Implication of allelic polymorphism of osteopontin in the development of lupus nephritis in MRL/lpr mice.
    Miyazaki T; Ono M; Qu WM; Zhang MC; Mori S; Nakatsuru S; Nakamura Y; Sawasaki T; Endo Y; Nose M
    Eur J Immunol; 2005 May; 35(5):1510-20. PubMed ID: 15832294
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antigen-specific T-cell hyporesponsiveness in MRL congenic mice can be explained by two independent cellular defects.
    Waterfield JD; Fairhurst M; Chu R; Levy JG
    Immunology; 1987 Jun; 61(2):173-8. PubMed ID: 2954899
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of FTY720 in MRL-lpr/lpr mice: therapeutic potential in systemic lupus erythematosus.
    Okazaki H; Hirata D; Kamimura T; Sato H; Iwamoto M; Yoshio T; Masuyama J; Fujimura A; Kobayashi E; Kano S; Minota S
    J Rheumatol; 2002 Apr; 29(4):707-16. PubMed ID: 11950011
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Resistance to tolerance induction is not prerequisite to development of murine SLE.
    Izui S; Masuda K
    J Immunol; 1984 Dec; 133(6):3010-4. PubMed ID: 6491280
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effect of thymectomy on lupus-prone mice.
    Hang L; Theofilopoulos AN; Balderas RS; Francis SJ; Dixon FJ
    J Immunol; 1984 Apr; 132(4):1809-13. PubMed ID: 6142069
    [TBL] [Abstract][Full Text] [Related]  

  • 19. B cell genotype determines the fine specificity of autoantibody in lpr mice.
    Kakkanaiah VN; Sobel ES; MacDonald GC; Cheek RL; Cohen PL; Eisenberg RA
    J Immunol; 1997 Jul; 159(2):1027-35. PubMed ID: 9218626
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [B-cell anomalies in systemic lupus erythematosus].
    Tron F; Jacquot S; Gilbert D
    Ann Med Interne (Paris); 2002 Dec; 153(8):503-12. PubMed ID: 12610424
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.